Member Info for beinthelead

Wyn - my reply was not meant to be rude, probably just frustration coming across.

My point; we have broken 241p a number of times and WE ARE NOT AWAY, due to news not arriving. I.e. if news arrived right now, at 238p, we’d be away. Likewise if it dragged, pulled back, and news arrived at 226p...

In terms of parking RNS news for now... as in when we’re days away from approval? If it was to be parked, we’d fall through this support you speak of, which you say is unlikely to be broken.

Surely you see the irony in this post, Wyn? You’re the one predicting domesday.

They have been manufacturing ahead of the CE. AS has confirmed this. It won’t be granted extension as a green light test, which is what the market is now wanting/requiring.

The Innova test is a good test at picking up highly infectious people, when used in in the correct way, by professionals. We’re in a different market and use case now. Red light to green light.

Thanks wallyj.

Especially liked this bit; “ with limited data on how well the tests perform when taken by people who do not have Covid symptoms”. Ours performs exceptionally. Perfect in fact.

Wyn - is this based on the chart? Why are charts able to predict a downtrend, but never the up? We’ve traded in a tight range for weeks now, all of which I’ve seen charts calling for breakouts to +300p...

Guess what, we’ve pulled back to where we are because of no news. I.e. when we broke 260p we didn’t progress to 300p because the chart said so.

I realise I’m stating the obvious, but some are susceptible to the subtle fear spread with these posts.

If we drop, we drop. You hold hoping for positive news, sell for negative.

The intraday thing... it’s a guess when 7am is missed. Someone will call it correctly, but it’s wild luck.

This isn’t known.

In terms of missing info to judge the LFT investment case... that’s a personal opinion. For me, there’s more than enough to judge the success. Specifically the world beating performance and contracted manufacturing capability. Which has/is stock piling the product as we speak.

We’ll get confirmation of first patient dosing before June 21st.

The delays are frustrating, they really are. Above everything - get the basics/easy stuff right. It destroys confidence if you don’t. This submission thing is farcical, someone will be moved on because of it.

That said, it’s a blip by a company destined to take over a new industry.

Ask yourself Roly - why aren’t all other companies printing money? They should be if they’re on that boat we’ve missed.

I don’t agree on the takeover target bit. We’ll smash through a few milestones before/if that happens.

Roly - what are LFT’s currently used for? As in, how are they employed?

I’ll give you a clue... not correctly. Do you know why? They’re not accurate or trusted enough to be used for Green light testing. This is the market we will take over, and Abbott won’t get a sniff of with their white label test.

Again - we’re not using LFT’s for the purpose they are destined for as yet. Hence ODX, Mologic, BBI, ABDX are selling nothing, but have invested millions gearing up for this new industry, to be dominated by AffiDx.

With respect, sell at near ATH’s if you’re predicting the worst.

A danger.

The seems to be the inference Wiggly. AIM is pure madness at times :)

D-Geeman - very clever. I hadn’t spotted that.

That does explain. Things a lot clearer, and the ‘it wasn’t our test’ bit.

The positives are that naivety has been tested and validated on many fronts. They should now have a competent team chasing this daily, whilst the customers wait for delivery.

They can’t risk another error and delay. Worst ways it delays the SP uptick for a further couple of weeks. Beyond frustrating, but AS appeared as frustrated in that RNS. I suspect rockets are now firmly up bottoms.

Hi Radds - Not sure it is. It’s the most clear statement of their lack of control of getting a product to market.

I’m buying more as I believe in the product and the markets they will disrupt.

For the third time?? :)

It has though. Massive supporter of the company, but this is by far the most damaging piece of news to date.

The same distributors they spoke about in their latest investor comm’s. Sweetener amongst the bitterness.

Very bad form running through to the 28th for re submission. Unless the error was dependant on the finalisation of something completed only recently?

I’ll be buying more, but mega frustrating.

When Simon says good luck, I’m not sure if he’s being sincere or sarcastic. I’ve asked him once before, but not heard.